Clinical Trial Update: PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT [Phase 2]

View source ↗

Summary

This Phase 2 trial comparing post-transplant cyclophosphamide (PTCy) plus ruxolitinib versus PTCy with tacrolimus and MMF in matched related donor and haploiden…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Graft-versus-host Disease

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Ruxolitinib (ruxolitinib)
• Tacrolimus (Tacrolimus)
• post-transplant cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Graft-versus-host-disease, Stem Cell Transplant Complications | Phase 2 | Status: COMPLETED